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Glucocorticoids are steroid hormones with strong anti-inflammatory and immunosuppressive 
effects that are produced in a diurnal fashion. Although glucocorticoids have the potential to 
induce interleukin-7 receptor (IL-7R) expression in T cells, whether they control T cell 
homeostasis and responses at physiological concentrations remains unclear. We found that 
glucocorticoid receptor signaling induces IL-7R expression in mouse T cells by binding to an 
enhancer of the IL-7Rα locus, with a peak at midnight and a trough at midday. This diurnal 
induction of IL-7R supported the survival of T cells and their redistribution between lymph 
nodes, spleen, and blood by controlling expression of the chemokine receptor CXCR4. In 
mice, T cell accumulation in the spleen at night enhanced immune responses against soluble 
antigens and systemic bacterial infection. Our results reveal the immunoenhancing role of 
glucocorticoids in adaptive immunity and provide insight into how immune function is 
regulated by the diurnal rhythm. 
 
 





Glucocorticoids are a group of steroid hormones that contribute to diverse biological 
processes, including glucose metabolism, cognition, and stress resistance. They also have 
strong anti-inflammatory and immunosuppressive effects, and are widely used in clinical 
practice. Glucocorticoids are produced by the adrenal cortex in response to 
adrenocorticotropic hormone in a diurnal fashion. In human, blood glucocorticoids levels 
peak in the morning and fall over the course of the day and the first part of the night. In 
nocturnal animals, such as mice, this circadian fluctuation is reversed. Glucocorticoids exert 
their functions by binding to glucocorticoid receptor (GR) in the cytoplasm. The GR is then 
transmitted to the nucleus, where it acts as a transcription factor by binding to glucocorticoid 
response elements (GREs) of target genes. GRs suppresses expression of inflammatory 
cytokines both directly, by binding to the corresponding gene loci, and indirectly, by binding 
to transcription factors such as AP-1 and NF-κB (Ashwell et al., 2000). Glucocorticoids 
induce apoptosis of CD4+CD8+ immature thymocytes (Screpanti et al., 1989). Nevertheless, 
T-cell development is not impaired in GR-deficient mice (Nr3c1–/–) (Purton et al., 2000). 
Hence, the physiological functions of glucocorticoids in the immune system remain unclear. 
 Glucocorticoids have a direct link with the immune system; for example, they induce 
the expression of IL-7 receptor α-chain (IL-7Rα) in T cells (Franchimont et al., 2002). IL-7, a 
cytokine critical for development and maintenance of the immune system (Mazzucchelli and 
Durum, 2007), is a member of common γ-chain cytokine family. By activating the 
transcription factor signal transducer and activator of transcription (STAT) 5 and 
phosphatidylinositol 3-kinase, IL-7R signaling promotes proliferation, survival, and 
differentiation of T cells. We previously reported that a GR binds to a GRE in an enhancer of 
the IL-7Rα locus and activates its transcription (Lee et al., 2005). Indeed, targeted deletion of 
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the IL-7Rα enhancer results in reduced expression of IL-7R and impaired survival and 
response of peripheral T cells (Abe et al., 2015). Furthermore, IL-7Rα enhancer–deficient 
mice totally lack IL-7R induction by glucocorticoids in T cells. These results suggest that 
glucocorticoids may promote T cell homeostasis by inducing IL-7R expression. 
 The circadian rhythm exerts a considerable influence on the immune system. 
Adrenergic neural signals regulate the adaptive immune response via diurnal lymphocyte 
recirculation in lymph nodes (Suzuki et al., 2016). More directly, the lymphocyte clock gene 
Arntl controls trafficking through lymph nodes and immune responses by regulating 
chemokine receptor CCR7 and sphingosine-1-phosphate receptor 1 (S1PR1) expression 
(Druzd et al., 2017). Because of their diurnal production, glucocorticoids are important 
circadian mediators. For example, glucocorticoids regulate the expression of intrinsic clock 
genes such as Per2 and Nfil3 and drive circadian change throughout the body (So et al., 2009). 
In addition, glucocorticoids control circadian changes of chemokine CXCL5 expression in 
pulmonary epithelial cells under inflammatory conditions and neutrophil recruitment (Gibbs 
et al., 2014), implying that glucocorticoids play roles in innate and adaptive immune 
responses. 
 To investigate whether glucocorticoids regulate T cell homeostasis and function in a 
diurnal rhythm by regulating IL-7R expression, we analyzed IL-7Rα enhancer GRE mutant 
and T cell specific GR-deficient mice (Nr3c1fl/flCd4-cre+). We found that IL-7R is induced by 
GRs in a diurnal rhythm, which supports T cell survival and recruitment to lymph nodes, 
spleen, and Peyer’s patches via CXCR4 expression. Moreover, the diurnal change in T cell 
distribution enhanced immune responses at night in mice. Collectively, our results 
demonstrate that adaptive immunity is under diurnal control by glucocorticoids, unveiling a 





GRs Regulate Diurnal Changes in IL-7R Expression and Numbers of T Cells in 
Lymphoid Organs 
To determine whether glucocorticoids regulate T cell homeostasis and activity in vivo, we 
examined IL-7R expression in T cell-specific GR-deficient (Nr3c1fl/flCd4-cre+) mice (Figure 
S1A). IL-7R expression was unchanged in most thymocytes, except for thymic regulatory T 
(Treg) cells, which exhibited reduced IL-7R expression (Figures S1B and S1C) but underwent 
normal development (Figures S1D–H). In the periphery, IL-7R expression was reduced in 
Nr3c1fl/flCd4-cre+ T cells (Figure 1A). Moreover, the reduction in IL-7R was observed only at 
night (Figure 1B). IL-7R expression changed in a diurnal fashion, with a peak at zeitgeber 
time (ZT, 24 hour light/dark cycle defining light on as time 0) 16 (night timepoint) and a nadir 
at ZT4 (day time point) in control mice, but was unchanged throughout the day in 
Nr3c1fl/flCd4-cre+ mice (Figure 1C). This change is likely to follow diurnal fluctuations in 
glucocorticoid levels (Gibbs et al., 2014). Diurnal variation of IL-7R expression was 
regulated at the mRNA level, and was lost in Nr3c1fl/flCd4-cre+ mice (Figure 1D), indicating 
that GRs regulate the diurnal rhythm of IL-7R expression in peripheral T cells. These results 
suggest that GRs might control diurnal changes in T cell functions. 
 To explore this possibility, we analyzed T cell numbers in peripheral lymphoid 
organs during the day. Circulating lymphocyte numbers fluctuate in human peripheral blood, 
rising at night and falling in daytime (Haus and Smolensky, 1999). In blood of control mice, 
absolute numbers of CD4+ T, CD8+ T, and Treg cells fluctuated, with a peak at ZT4 and a 
nadir at ZT16 (Figure 1E). By contrast, T cell counts in blood were lower in Nr3c1fl/flCd4-cre+ 
mice than in controls, and the difference between day and night was lost. Due to the diurnal 
change of T cell numbers in blood, we hypothesized that T cells recirculate between lymphoid 
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tissue and blood during the day. Indeed, the T cell count in lymph nodes exhibited a diurnal 
fluctuation with a peak at ZT12 and a nadir at ZT0, and this fluctuation was lost in 
Nr3c1fl/flCd4-cre+ mice (Figure 1F), consistent with a previous report (Druzd et al., 2017). In 
the spleen and Peyer’s patches of control mice, T cell numbers exhibited the changes opposite 
to the blood, with a peak at ZT16 and a nadir at ZT4, and again this fluctuation was lost in 
Nr3c1fl/flCd4-cre+ mice (Figures 1G and 1H). These results suggest that GRs control T cell 
distribution between lymphoid organs and peripheral blood. 
 
GRs Regulate IL-7R Upregulation by Binding to GR Motifs in IL-7R Enhancer in vivo 
Previously, we showed that GRs regulate IL-7R expression through an enhancer of the 
IL-7Rα locus, conserved non-coding sequence (CNS)-1 (Abe et al., 2015). To determine 
whether GR directly regulates IL-7R expression in vivo, we generated mice harboring point 
mutations in one or both of two glucocorticoid response elements (GREs) in the IL-7Rα 
enhancer (Figures S2A–S2C). IL-7R expression was reduced in thymic Treg and peripheral T 
cells, but not in other thymocyte subsets, in IL7R-CNS1-GRE mutant mice (Figures 2A, 
S2D–S2F, and S3A–S3D). Il7rCNS1.GRE1m/1m (GRE1m) and Il7rCNS1.GRE2m/2m (GRE2m) mice, 
with mutations in single motifs, had reduced levels of Il7r mRNA and cell-surface IL-7R, 
whereas Il7rCNS1.GRE12m/12m (GRE12m) mice with mutations in both motifs exhibited more 
severe reductions. We then performed flow cytometry to further confirm the change in IL-7R 
expression on T cells during the day. IL-7R expression changed in a diurnal fashion with a 
peak at ZT16 and a nadir at ZT4 in control mice, but was unchanged throughout the day in 
GRE12m mice (Figure 2B). The levels of IL-7Rα mRNA also exhibited a similar diurnal 
change (Figure 2C). Next, we performed a chromatin immunoprecipitation (ChIP) assay to 
investigate whether GR binds to the CNS-1 in a diurnal fashion. Specific GR binding was 
observed only at night in T cells of WT mice, but this binding was completely lost in T cells 
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of GRE12m mice (Figure 2D). 
 Next, we sought to elucidate the function of GR-induced IL-7R in vivo. The 
phenotype of GRE12m mice was similar to that of Nr3c1fl/flCd4-cre+ mice, i.e., they lacked 
the diurnal redistribution of T cells between lymphoid tissues and peripheral blood (Figures 
2E–2H). To determine whether IL-7R controls the diurnal redistribution of T cells, we 
analyzed T cell-specific IL-7R–deficient (Il7rfl/flCd4-cre+) mice. Although these mice 
exhibited a severe reduction in T cell numbers relative to control mice, the diurnal 
redistribution of T cells was lost (Figures S3E–S3G). These findings confirmed the previous 
study showing that GRs upregulate IL-7R expression by binding directly to the GRE in the 
IL-7Rα enhancer. Furthermore, these results suggest that GR-induced IL-7R expression 
regulates the diurnal change in T cell distribution between lymphoid tissues and peripheral 
blood. 
 
GRs Regulate T Cell Survival through IL-7R and Bcl2 Expression 
To assess whether the reduction of IL-7R affects T cell survival, we first cultured naive T 
cells with IL-7 for 6 days. IL-7 rescued fewer T cells in Nr3c1fl/flCd4-cre+ and GRE12m mice 
than in control mice (Figures S4A and S4B). To determine whether T cell survival was 
impaired in vivo, we labeled CD45.1+ (control) and CD45.2+ (Nr3c1fl/flCd4-cre+ or GRE12m) 
naive CD4 T cells with CFSE, mixed them, and transferred them into CD45.2+ C57BL/6 mice. 
After 8 days, we compared the frequencies of T cells in spleen, lymph nodes, and peripheral 
blood between control and GRE12m mice. GRE12m T cells were less abundant than control 
T cells (Figures S4C and S4D). Furthermore, the phenotype of Nr3c1fl/flCd4-cre+ T cells was 
more severe than that of GRE12m T cells. Next, to determine whether T cells die at higher 
rates during the daytime, we compared levels of activated caspase 3, an indicator of cell death, 
in freshly isolated naïve CD4+ T cells. CD4+ T cells of control mice contained higher levels of 
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activated caspase 3 in the daytime than at night (Figure S4E). We then analyzed the 
expression of anti-apoptotic factors, Bcl2 and BclxL. Nr3c1fl/flCd4-cre+ mice expressed 
reduced levels of Bcl2 and BclxL in peripheral T cells and thymocytes (Figures S4F–S4H), 
whereas GRE12m mice did not (Figures S4I–S4K). These results suggest that GR supports T 
cell survival by both IL-7R–dependent and –independent pathways. Moreover, the data 
suggest that impaired T cell survival might play some role in the impaired T cell oscillations 
in the GRE12m mice. In addition, although the expression of Bcl2 and BclxL was reduced in 
the thymocytes of Nr3c1fl/flCd4-cre+ mice, their cell numbers were unchanged (Figure 
S1D–H). 
 
GRs and IL-7R Regulate the Diurnal Change of T Cell Distribution by Inducing 
CXCR4 Expression 
We next sought to elucidate the mechanism controlling the diurnal redistribution of T cells. In 
light of previous reports that CXCR4 is induced by glucocorticoids and IL-7 (Dimitrov et al., 
2009; Jourdan et al., 2000), we monitored expression of two chemokine receptors, CXCR4 
and CCR7, on naïve T cells. CCR7 expression was unchanged in Nr3c1fl/flCd4-cre+ mice 
relative to control mice (Figure S5A). Levels of CXCR4 protein and mRNA were high at 
night and low in the daytime in CD4+ and CD8+ T cells of control mice (Figures 3A–3F). By 
contrast, nighttime levels of CXCR4 mRNA were reduced in Nr3c1fl/flCd4-cre+ and GRE12m 
mice, and the diurnal variation in CXCR4 expression was lost in Nr3c1fl/flCd4-cre+ and 
GRE12m mice. To determine whether the diurnal change in CXCR4 expression influences 
the migration of T cells, we performed Transwell migration assays with chemokine CXCL12. 
In control mice, T cells isolated at night migrated more efficiently than those isolated in the 
daytime (Figures 3G and 3H), but this difference was abolished in Nr3c1fl/flCd4-cre+ and 
GRE12m mice. These results suggest that CXCR4 upregulation might cause T cell homing to 
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the spleen at night. 
 To determine whether T cell homing to spleen is impaired in mutant mice, we mixed 
CD45.1+ (control) and CD45.2+ (Nr3c1fl/flCd4-cre+ or GRE12m) CD4+ T cells, labeled them 
with CFSE, and transferred them into recipient mice at daytime or night. When T cells were 
transferred at night the frequency of mutant T cells in spleen was reduced relative to control T 
cells, whereas their frequency in peripheral blood was elevated (Figures 3I and 3J); this effect 
was not observed when the cells were transferred at daytime. Next, to assess whether CXCR4 
controls T cell redistribution, we analyzed T cell-specific CXCR4-deficient 
(Cxcr4fl/flCd4-cre+) mice. Unlike control mice, Cxcr4fl/flCd4-cre+ mice lacked the diurnal 
change in T cell numbers in blood, lymph nodes, and spleen (Figures 3K–3M). T cell 
numbers in blood are kept at higher levels in Cxcr4fl/flCd4-cre+ mice, suggesting that the 
impairment of homing alone does not lead to decreased cell survival. Otherwise, there was no 
difference between control and Cxcr4fl/flCd4-cre+ T cells in terms of CD127 and Bcl2 
expression or in vivo survival (Figures S5B–S5D). These results indicate that IL-7R induced 
by GRs regulates CXCR4 expression in a diurnal fashion, and that CXCR4 is critical for the 
diurnal change in T cell distribution between lymphoid organs and blood. 
 We next tested whether the administration of glucocorticoids in vivo induces the 
expression of IL-7R and CXCR4 in T cells and their accumulation in spleen. IL-7R 
expression was elevated in CD4+ T cells 4 hr after dexamethasone injection at ZT4 (Figure 
S5E). Concurrently, CXCR4 was induced in CD4+ T cells. The numbers of CD4+ T cells were 
also elevated in spleen. These results demonstrate that exogenous glucocorticoids recapitulate 
the induction of IL-7R and CXCR4 expression and the redistribution of T cells between 
spleen and blood. By contrast, IL-7 administration alone, neither in vivo nor in vitro, did not 
change CXCR4 expression in CD4+ T cells (Figures S5F and S5G), suggesting that IL-7 is 
required, but not sufficient, for CXCR4 expression. 
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GRs Regulate T-Cell Homing to CXCL12-Producing Cells 
Because CXCR4 is important for the diurnal rhythm of T cell migration, and its expression 
depended on IL-7 signaling, we next investigated whether GR controls T cell migration near 
CXCL12- and IL-7-producing cells in spleen and Peyer’s patches. In spleen, CXCL12 is 
strongly expressed in red pulp and a subset of vessels in the T and B cell zones (Figures 4A 
and 4B). As expected, donor T cells accumulated around the CXCL12-expressing area, red 
pulp, and vessels. On the other hand, IL-7-expressing cells were scattered in the T cell zone 
and around vessels (Figures 4C and 4D). T cells seemed to localize around vessels surrounded 
by IL-7–expressing cells in the T and B cell zones. To determine whether T cell homing is 
impaired in Nr3c1fl/flCd4-cre+ mice, we labeled T cells from control and Nr3c1fl/flCd4-cre+ 
mice with different dyes, mixed them 1:1, and transferred them into Cxcl12-GFP mice. T cells 
from control mice localized more frequently in the vicinity of CXCL12+ cells than T cells 
from Nr3c1fl/flCd4-cre+ mice (Figures 4E and 4F). In Peyer’s patches, we detected GFP signal 
in and around the T cell zone (Figures S6A and S6B). T cells from control mice tended to 
localize near CXCL12+ cells around the T cell zone. In contrast to spleen, vessels in Peyer’s 
patches were surrounded by IL-7-expressing cells, but not by CXCL12+ cells (Figures S6B 
and S6C), and T cells from Nr3c1fl/flCd4-cre+ mice migrated less in Peyer’s patches (Figures 
S6D and S6E). These results indicate that CXCR4 expression induced by GRs regulates T cell 
homing to CXCL12-producing cells in spleen. 
 
GRs Enhance IL-2 Response and T Cell Activation in a Diurnal Fashion 
Because T cell priming occurs in lymphoid tissues, we hypothesized that T cell accumulation 
at night might induce efficient T cell activation in spleen and Peyer’s patches. Because 
glucocorticoids and IL-7 up-regulate IL-2 receptor α chain (CD25) expression (Franchimont 
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et al., 2002), we first analyzed T cell activation after stimulation with anti-CD3 and 
anti-CD28 antibodies. Nr3c1fl/flCd4-cre+ CD4+ and CD8+ T cells isolated at ZT4 and ZT16 
exhibited impaired proliferation, whereas GRE12m T cells did not (Figures 5A and S7A). 
Consistently, Nr3c1fl/flCd4-cre+ T cells showed reduction in CD25 expression and STAT5 
phosphorylation, whereas GRE12m T cells did not (Figures 5B, 5C, and S7B). On the other 
hand, IL-2 receptor β chain (CD122) expression was slightly elevated in Nr3c1fl/flCd4-cre+ T 
cells. These results suggest that GR signal, independently of IL-7R expression, controls the 
proliferation of T cells after T cell receptor (TCR) stimulation. Next, we infected control and 
Nr3c1fl/flCd4-cre+ mice with Listeria monocytogenes expressing ovalbumin (OVA) and 
analyzed OVA-specific CD8+ T cells. In control mice, the percentages and cell numbers of 
OVA-specific CD8+ T cells were higher when mice were both infected and analyzed at night 
than when the manipulations were performed during the daytime (Figures 5D and 5E). By 
contrast, Nr3c1fl/flCd4-cre+ mice had reduced numbers of OVA-specific CD8+ T cells, with a 
less prominent diurnal change. Moreover, GRE12m mice showed similar phenotype to 
Nr3c1fl/flCd4-cre+ mice (Figures 5F and 5G), even though T cell proliferation after TCR 
stimulation was not impaired. These results indicate that glucocorticoids enhance the 
responsiveness of CD8+ T cells on a per-cell basis at night, in addition to increasing their 
absolute cell numbers. 
 
GRs Control Differentiation of Th Subsets and Immune Response of B Cells 
Because glucocorticoids influence type1 helper T (Th1) and Th2 cell balance (Elenkov, 2004), 
we next analyzed the differentiation of naive CD4+ T cells into Th1 and Th2 cells. 
Differentiation of interferon (IFN)-γ–producing cells was elevated in Nr3c1fl/flCd4-cre+ T 
cells, whereas differentiation of IL-4– and IL-13–producing cells was reduced (Figures S7C 
and S7D). The transcription factor E4BP4 is induced by glucocorticoids (So et al., 2009) and 
 12 
regulates Th2 cytokine production (Kashiwada et al., 2011; Motomura et al., 2011). 
Consistent with this, expression of E4BP4, but not GATA binding protein 3 (GATA3) was 
reduced in Nr3c1fl/flCd4-cre+ T cells cultured under Th2-inducing conditions (Figure S7E). 
We next immunized control and Nr3c1fl/flCd4-cre+ mice with OVA at ZT16. After 7 days, the 
spleen cells were stimulated with OVA for 3 days. Production of IL-4 and IL-13 was 
significantly impaired in Nr3c1fl/flCd4-cre+ mice, and levels of IL-4 and IL-13 mRNAs were 
also reduced in follicular helper T (Tfh) cells of Nr3c1fl/flCd4-cre+ mice (Figures S7F and 
S7G). By contrast, GRE12m mice exhibited no change in Th cell differentiation (Figure S7H). 
These results suggest that GRs control Th cell differentiation independently of IL-7R 
expression. 
 Next, to assess whether the B cell immune response also follows a diurnal rhythm 
influenced by glucocorticoids, we immunized Nr3c1fl/flCd4-cre+ mice with OVA at night or 
daytime. Similar to effector CD8+ T cells, this immunization induced Tfh cells, germinal 
center B cells, and immunoglobulin (Ig) G1+ B cells in a diurnal rhythm (high at night and 
low in the daytime) in control mice, but this diurnal change was impaired in Nr3c1fl/flCd4-cre+ 
mice (Figures 6A–C). In addition, production of NP-specific IgG1 and IgG2b was reduced in 
Nr3c1fl/flCd4-cre+ mice at night, and the diurnal rhythm was lost (Figure 6D). The diurnal 
induction of Tfh cells, germinal center B cells, and IgG1+ B cells was reduced in GRE12m 
mice (Figure S7I). These results indicate that GRs control B cell immune responses via Tfh 
cells in a diurnal fashion, dependent on IL-7R expression. 
 Peyer’s patches are lymphoid tissues in which germinal centers are induced by 
commensal microbiota even in the absence of immunization (Harada et al., 2012). In Peyer’s 
patches of control mice, the numbers of Tfh cells, germinal center B cells, and IgG1+ B cells 
were unchanged between daytime and night, and their numbers were reduced in 
Nr3c1fl/flCd4-cre+ mice (Figures 6E and 6F), whereas those of GRE12m mice exhibited less 
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distinct reductions (Figure S7J). These results suggest that GRs might have a permissive 
effect on the T cell–mediated B cell response, independent of IL-7R expression. 
 
GRs Support Maintenance of Memory CD4+ T Cells by Regulating IL-7R Expression 
Because IL-7R is expressed at higher levels in memory T cells and is critical for their survival 
(Kondrack et al., 2003; Schluns et al., 2000), we next tested whether glucocorticoids regulate 
IL-7R expression in memory CD4+ T cells. Because the function of Th2 cells was impaired in 
Nr3c1fl/flCd4-cre+ mice, we generated memory Th2 cells using an adoptive transfer model 
(Endo et al., 2011). First, we cultured naïve T cells under Th2 conditions for 6 days, and then 
transferred the effector T cells into B6.CD45.1+ mice. After 4 weeks, we analyzed IL-7R 
expression in CD45.2+ memory T cells in spleen. Similar to naïve T cells IL-7R expression 
was reduced in Nr3c1fl/flCd4-cre+ and GRE12m memory T cells in comparison with control 
cells (Figures 7A and 7B). Furthermore, the diurnal change in IL-7R expression was lost in 
the mutant memory T cells (Figure 7C). The numbers of Nr3c1fl/flCd4-cre+ and GRE12m 
memory T cells were reduced in spleen, lymph nodes, and lungs: Nr3c1fl/flCd4-cre+ cells were 
more severely reduced than GRE12m cells (Figure 7D). As in naïve T cells, Bcl-2 expression 
was reduced in Nr3c1fl/flCd4-cre+ cells, but not in GRE12m cells (Figure 7E). These results 
indicate that IL-7R induction by GRs is important for maintenance of memory T cells. 
 
DISCUSSION 
In contrast to the longstanding view that glucocorticoids have strong anti-inflammatory and 
immunosuppressive effects, this study revealed that glucocorticoids are immunoenhancing. 
We found that glucocorticoids and GR directly induce IL-7R expression in T cells in diurnal 
fashion through binding to the IL-7Rα enhancer. The elevated IL-7R induces T cell homing 
to peripheral lymphoid organs via CXCR4 expression and enhances immune responses of T 
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and B cells at night in mice. Our use of GRE12m mice was crucial in leading us to this 
understanding. The diurnal redistribution of T cells by glucocorticoids may facilitate 
recirculation and long-term survival of a wide range of T cell clones. Because glucocorticoids 
also induce IL-7R expression in human T cells (Franchimont et al., 2002), it is possible that 
this immunoenhancing function of glucocorticoids also operates in humans. 
 Although our findings suggest that glucocorticoids and IL-7 are important for T cell 
survival, whether or how cell survival contributes to the diurnal redistribution of T cells is not 
fully understood. Because T cell survival is impaired in Nr3c1fl/flCd4-cre+ and GRE12m mice, 
there is a possibility that the impaired survival might have some role in the impaired 
oscillations in T cell numbers in the mutant mice. However, Cxcr4fl/flCd4-cre+ mice exhibit 
substantial impairment of the diurnal redistribution of T cells without any defects in survival, 
which suggests that the impairment of homing alone does not necessarily lead to decreased 
cell numbers in blood. Thus, CXCR4 expression seems to play more important role in the 
diurnal redistribution than cell survival. 
 Our findings have important implications regarding the circadian changes of the 
immune system. Blood glucocorticoid levels rise during active phases in daily life, when the 
risk of injury and infection increase. The resultant T cell accumulation in the spleen would 
help to combat invading microorganisms. Consistent with this, the immune system is under 
the control of the diurnal rhythm. Previous studies showed that innate immune cells 
efficiently respond to bacterial infections at night (Curtis et al., 2014). Circadian CXCL12 
expression induces migration of aged neutrophils to bone marrow and their engulfment by 
tissue-resident macrophages (Casanova-Acebes et al., 2013), and liver X receptor in 
macrophages regulates circadian expression of phagocytosis-related genes. In addition, the 
expression of Toll-like receptor (TLR) 9 is high at dusk in macrophages and B cells (Silver et 
al., 2012). Moreover, the levels of inflammatory cytokines and B7 costimulatory molecules 
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are higher at night than in daytime in spleen (Silver et al., 2012), suggesting that antigen 
presentation might be enhanced at night. In vitro proliferation of lymph node T cells is more 
rapid when the cells are isolated at night than during the daytime, largely due to higher 
signaling molecule ZAP-70 expression, whereas the T cell response is stronger when mice are 
immunized during the daytime than at night (Fortier et al., 2011). Some of these time points 
correspond to the glucocorticoid-induced diurnal rhythm of T cell redistribution to the spleen. 
 The circadian changes of the immune system are controlled by at least three 
mechanisms. First, adrenergic neural signals regulate the adaptive immune response by 
diurnal lymphocyte recirculation in lymph nodes (Suzuki et al., 2016). Second, the 
lymphocyte clock gene Arntl controls trafficking through the lymph nodes and immune 
responses by regulating CCR7 and S1PR1 expression (Druzd et al., 2017). These two 
pathways are primarily responsible for regulating lymphocyte recirculation through peripheral 
lymph nodes. Third, glucocorticoids regulate diurnal redistribution of T cells between blood 
and lymphoid organs and enhance the immune response in spleen. Together, these 
mechanisms may create the temporal difference in the oscillations of T cell numbers between 
lymph nodes and spleen. More detailed analysis will help to reveal a more comprehensive 
view of the diurnal change in lymphocyte distribution in the lymphoid organs. 
 Glucocorticoids control T cell functions by IL-7R–dependent and –independent 
mechanisms. We showed that diurnal T cell redistribution via CXCR4 is regulated similarly 
in Nr3c1fl/flCd4-cre+ and GRE12m mice, suggesting that this process depends mainly on an 
IL-7R–dependent mechanism. By contrast, Nr3c1fl/flCd4-cre+ mice exhibited more severe 
phenotypes in terms of survival of naïve and memory T cells, as well as the immune response 
of CD8+ T cells, than GRE12m mice. Glucocorticoids probably regulate these immune 
functions by both IL-7R–dependent and –independent mechanisms. Finally, differentiation of 
Th subsets and the B cell immune response are impaired in Nr3c1fl/flCd4-cre+ and GRE12m 
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mice, suggesting that glucocorticoids regulate these processes mainly via an IL-7R–dependent 
mechanism. GRs may exert IL-7R–independent functions by activating other target genes, 
such as Nfil3, or by directly interacting with other transcription factors. 
 GRs control the differentiation and response of Th subsets in multiple mechanisms. 
Our findings revealed that GRs enhance Th2 cytokine production and the B cell immune 
response, whereas GRs suppress Th1 differentiation. Glucocorticoids inhibit Th1 
differentiation by suppressing transcription factors such as AP-1, NF-κB, and NFAT 
(Ashwell et al., 2000), and also suppress STAT4 and T box transcription factor 21 (TBX21) 
signals (Franchimont et al., 2000; Liberman et al., 2007). In addition, our results demonstrate 
that E4BP4 expression is impaired in Nr3c1fl/flCd4-cre+ mice. E4BP4 is important for 
regulation of IL-4 and IL-13 production (Kashiwada et al., 2011), and GRs induce 
transcription of the Nfil3 gene by binding to its promoter (So et al., 2009). Therefore, our 
findings suggest that GRs might enhance IL-4 and IL-13 production by inducing E4BP4. 
Because Nfil3 is itself a clock gene, and its expression is higher at night, the GR–E4BP4 axis 
might be important for the diurnal change in the Th2 immune response. Furthermore, we 
demonstrate that GRs support the survival of memory Th2 cells via diurnal IL-7R induction. 
Because the IL-7 signal helps to produce Th2 cytokines (Guo et al., 2015), GRs might 
enhance the Th2 immune response. 
 Steroid hormones, including glucocorticoids, mineralocorticoids, androgens, and 
estrogens, may have a strong influence on the immune system. Not only glucocorticoids, but 
also androgens and estrogens, are produced from adrenal cortex in diurnal fashion. In this 
study, we demonstrated that glucocorticoids enhance the responses of T and B cells by 
inducing IL-7R expression and T cell redistribution to the lymphoid organs. In addition, our 
study suggests that glucocorticoids prevent Th1 differentiation and augment Th2 
differentiation. In addition to glucocorticoids, androgens inhibit Th1 differentiation, whereas 
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estrogens enhance IFN-γ and IL-10 production (Gilmore et al., 1997; Kissick et al., 2014; 
Miyaura and Iwata, 2002). Furthermore, these effects might be under the control of the 
circadian cycle, which might in turn be related to the observation that the symptoms of asthma 
and rheumatoid arthritis tend to be exacerbated in the morning. Thus, it is likely that many 
aspects of immunity are under the control of steroid hormones. Future studies should seek to 
resolve immunological phenomena from the perspective of steroid hormones. 
 Glucocorticoids may control mucosal immunity by various mechanisms. We 
revealed that the GR–IL-7R axis induces diurnal T cell homing to Peyer’s patches, and that 
glucocorticoids enhance Tfh cell differentiation and B cell responses in Peyer’s patches. 
These observations suggest a new role for glucocorticoids in mucosal immunity. The mucosal 
immune system is influenced by circadian oscillations, such as food digestion and the activity 
of commensal bacteria (Hussain and Pan, 2009). This may in turn trigger TLR activation and 
inflammatory cytokine production, which, together with T cell accumulation by 
glucocorticoids, help the mucosal immune system to clear invading bacteria. In addition, 
intestinal epithelial cells produce glucocorticoids in a circadian fashion (Cima et al., 2004; 
Hussain and Pan, 2009; Mukherji et al., 2013), suggesting that intestinal glucocorticoids 
might also enhance mucosal immunity. The roles of glucocorticoids in mucosal immunity 
should be investigated in future studies. 
 Because glucocorticoids are stress-responsive hormones, their irregular production 
during periods of high stress, shift work, and chronic fatigue may cause impairment of the 
immune functions investigated in this study. On the other hand, clinical administration of 
synthetic glucocorticoids, which might have stronger affinity for GRs, probably perturbs the 
diurnal change in endogenous glucocorticoid levels, thereby diminishing the 




We would like to acknowledge Drs. J. Takeda, K. Yusa, and G. Kondoh for providing the 
KY1.1 ES line and targeting system; and Dr. Batu Erman and members of the K. Ikuta 
laboratory for discussion. This work was supported by JSPS KAKENHI Grant Numbers 
16K15288, 16H05172, and 15H01153 (K.I.), 26460572 (S.T.), and 16K08835 (T.H.); by the 
Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences 
Kyoto University; by the Future Developmental Funding Program of Kyoto University 
Research Coordination Alliance; and by the Japan Society for the Promotion of Science 
(JSPS) and TUBITAK Joint Research Project. A.S. was supported by the Platform for 
Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, 
Science and Technology (MEXT) and Japan Agency for Medical Research and Development 




A.S. designed and performed experiments and wrote the paper. G.C., S.T., M.O., S.A., F.O., 
and T.H. performed some experiments. S.K. and H.M. generated GRE mutant mice. H.Y. and 
Y.Y. provided LM-OVA and supervised some studies. T.N. provided Cxcr4fl/fl and 
Cxcl12-GFP mice. G.S. provided Nr3c1fl/fl mice. K.I. conceptualized and supervised studies, 
designed and performed some experiments, discussed the data, and wrote the paper. 
 
Declaration of Interests 




Abe, A., Tani-ichi, S., Shitara, S., Cui, G., Yamada, H., Miyachi, H., Kitano, S., Hara, T., Abe, 
R., Yoshikai, Y., and Ikuta, K. (2015). An enhancer of the IL-7 receptor α−chain locus 
controls IL-7 receptor expression and maintenance of peripheral T cells. J. Immunol. 195, 
3129-3138. 
Ara, T., Itoi, M., Kawabata, K., Egawa, T., Tokoyoda, K., Sugiyama, T., Fujii, N., Amagai, T., 
and Nagasawa, T. (2003). A role of CXC chemokine ligand 12/stromal cell-derived 
factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell 
development in vivo. J. Immunol. 170, 4649-4655. 
Ashwell, J.D., Lu, F.W.M., and Vacchio, M.S. (2000). Glucocorticoids in T cell development 
and function. Annu. Rev. Immunol. 18, 309-345. 
Casanova-Acebes, M., Pitaval, C., Weiss, L.A., Nombela-Arrieta, C., Chevre, R., A-Gonzalez, 
N., Kunisaki, Y., Zhang, D.C., van Rooijen, N., Silberstein, L.E., et al. (2013). Rhythmic 
modulation of the hematopoietic niche through neutrophil clearance. Cell 153, 1025-1035. 
Cima, I., Corazza, N., Dick, B., Fuhrer, A., Herren, S., Jakob, S., Ayuni, E., Mueller, C., and 
Brunner, T. (2004). Intestinal epithelial cells synthesize glucocorticoids and regulate T cell 
activation. J. Exp. Med. 200, 1635-1646. 
Cui, G.W., Hara, T., Simmons, S., Wagatsuma, K., Abe, A., Miyachi, H., Kitano, S., Ishii, M., 
Tani-ichi, S., and Ikuta, K. (2014). Characterization of the IL-15 niche in primary and 
secondary lymphoid organs in vivo. Proc. Natl. Acad. Sci. USA. 111, 1915-1920. 
Curtis, A.M., Bellet, M.M., Sassone-Corsi, P., and O'Neill, L.A.J. (2014). Circadian clock 
proteins and immunity. Immunity 40, 178-186. 
Dimitrov, S., Benedict, C., Heutling, D., Westermann, J., Born, J., and Lange, T. (2009). 
 20 
Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood 113, 
5134-5143. 
Druzd, D., Matveeva, O., Ince, L., Harrison, U., He, W.Y., Schmal, C., Herzel, H., Tsang, 
A.H., Kawakami, N., Leliavski, A., et al. (2017). Lymphocyte circadian clocks control lymph 
node trafficking and adaptive immune responses. Immunity 46, 120-132. 
Elenkov, I.J. (2004). Glucocorticoids and the Th1/Th2 balance. Ann. N. Y. Acad. Sci. 1024, 
138-146. 
Endo, Y., Iwamura, C., Kuwahara, M., Suzuki, A., Sugaya, K., Tumes, D.J., Tokoyoda, K., 
Hosokawa, H., Yamashita, M., and Nakayama, T. (2011). Eomesodermin controls 
interleukin-5 production in memory T helper 2 cells through inhibition of activity of the 
transcription factor GATA3. Immunity 35, 733-745. 
Fortier, E.E., Rooney, J., Dardente, H., Hardy, M.P., Labrecque, N., and Cermakian, N. 
(2011). Circadian variation of the response of T cells to antigen. J. Immunol. 187, 6291-6300. 
Franchimont, D., Galon, J., Gadina, M., Visconti, R., Zhou, Y.J., Aringer, M., Frucht, D.M., 
Chrousos, G.P., and O'Shea, J.J. (2000). Inhibition of Th1 immune response by 
glucocorticoids, dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T 
lymphocytes. J. Immunol. 164, 1768-1774. 
Franchimont, D., Galon, J., Vacchio, M.S., Fan, S., Visconti, R., Frucht, D.M., Geenen, V., 
Chrousos, G.P., Ashwell, J.D., and O'Shea, J.J. (2002). Positive effects of glucocorticoids on 
T cell function by up-regulation of IL-7 receptor α. J. Immunol. 168, 2212-2218. 
Gibbs, J., Ince, L., Matthews, L., Mei, J.J., Bell, T., Yang, N., Saer, B., Begley, N., Poolman, 
T., Pariollaud, M., et al. (2014). An epithelial circadian clock controls pulmonary 
inflammation and glucocorticoid action. Nat. Med. 20, 919-926. 
Gilmore, W., Weiner, L.P., and Correale, J. (1997). Effect of estradiol on cytokine secretion 
 21 
by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and 
normal control subjects. J. Immunol. 158, 446-451. 
Guo, L.Y., Huang, Y.F., Chen, X., Hu-Li, J., Urban, J.F., and Paul, W.E. (2015). Innate 
immunological function of TH2 cells in vivo. Nat. Immunol. 16, 1051-1059. 
Hara, T., Shitara, S., Imai, K., Miyachi, H., Kitano, S., Yao, H., Tani-ichi, S., and Ikuta, K. 
(2012). Identification of IL-7-producing cells in primary and secondary lymphoid organs 
using IL-7-GFP knock-in mice. J. Immunol. 189, 1577-1584. 
Harada, Y., Tanaka, S., Motomura, Y., Ohno, S., Yanagi, Y., Inoue, H., and Kubo, M. (2012). 
The 3' enhancer CNS2 is a critical regulator of interleukin-4-mediated humoral immunity in 
follicular helper T cells. Immunity 36, 188-200. 
Hata, K., Yanase, N., Sudo, K., Kiyonari, H., Mukumoto, Y., Mizuguchi, J., and Yokosuka, T. 
(2016). Differential regulation of T-cell dependent and T-cell independent antibody responses 
through arginine methyltransferase PRMT1 in vivo. FEBS Lett. 590, 1200-1210. 
Haus, E., and Smolensky, M.H. (1999). Biologic rhythms in the immune system. Chronobiol. 
Int. 16, 581-622. 
Hussain, M.M., and Pan, X.Y. (2009). Clock genes, intestinal transport and plasma lipid 
homeostasis. Trends. Endocrinol. Metab. 20, 177-185. 
Jourdan, P., Vendrell, J.P., Huguet, M.F., Segondy, M., Bousquet, J., Pene, J., and Yssel, H. 
(2000). Cytokines and cell surface molecules independently induce CXCR4 expression on 
CD4+ CCR7+ human memory T cells. J. Immunol. 165, 716-724. 
Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakai, M., Sakaki, T., Sugano, S., and Saito, I. 
(1995). Efficient gene activation in mammalian cells by using recombinant adenovirus 
expressing site-specific Cre recombinase. Nucleic Acids Res. 23, 3816-3821. 
 
 22 
Kashiwada, M., Cassel, S.L., Colgan, J.D., and Rothman, P.B. (2011). NFIL3/E4BP4 controls 
type 2 T helper cell cytokine expression. EMBO. J. 30, 2071-2082. 
Kissick, H.T., Sanda, M.G., Dunn, L.K., Pellegrini, K.L., On, S.T., Noel, J.K., and 
Arredouani, M.S. (2014). Androgens alter T-cell immunity by inhibiting T-helper 1 
differentiation. Proc. Natl. Acad. Sci. USA. 111, 9887-9892. 
Kondrack, R.M., Harbertson, J., Tan, J.T., McBreen, M.E., Surh, C.D., and Bradley, L.M. 
(2003). Interleukin 7 regulates the survival and generation of memory CD4 cells. J. Exp. Med. 
198, 1797-1806. 
Lee, H.C., Shibata, H., Ogawa, S., Maki, K., and Ikuta, K. (2005). Transcriptional regulation 
of the mouse IL-7 receptor α promoter by glucocorticoid receptor. J. Immunol. 174, 
7800-7806. 
Lee, P.P., Fitzpatrick, D.R., Beard, C., Jessup, H.K., Lehar, S., Makar, K.W., Perez-Melgosa, 
M., Sweetser, M.T., Schlissel, M.S., Nguyen, S., et al. (2001). A critical role for Dnmt1 and 
DNA methylation in T cell development, function, and survival. Immunity 15, 763-774. 
Liberman, A.C., Refojo, D., Druker, J., Toscano, M., Rein, T., Holsboer, F., and Arzt, E. 
(2007). The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct 
protein-protein interaction. FASEB J. 21, 1177-1188. 
Mazzucchelli, R., and Durum, S.K. (2007). Interleukin-7 receptor expression: intelligent 
design. Nat. Rev. Immunol. 7, 144-154. 
Miyaura, H., and Iwata, M. (2002). Direct and indirect inhibition of Th1 development by 
progesterone and glucocorticoids. J. Immunol. 168, 1087-1094. 
Motomura, Y., Kitamura, H., Hijikata, A., Matsunaga, Y., Matsumoto, K., Inoue, H., Atarashi, 
K., Hori, S., Watarai, H., Zhu, J.F., et al. (2011). The transcription factor E4BP4 regulates the 
production of IL-10 and IL-13 in CD4+ T cells. Nat. Immunol. 12, 450-U111. 
 23 
Mukherji, A., Kobiita, A., Ye, T., and Chambon, P. (2013). Homeostasis in intestinal 
epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. 
Cell 153, 812-827. 
Pope, C., Kim, S.K., Marzo, A., Masopust, D., Williams, K., Jiang, J., Shen, H., and 
Lefrancois, L. (2001). Organ-specific regulation of the CD8 T cell response to Listeria 
monocytogenes infection. J. Immunol. 166, 5840-5840. 
Purton, J.F., Boyd, R.L., Cole, T.J., and Godfrey, D.I. (2000). Intrathymic T cell development 
and selection proceeds normally in the absence of glucocorticoid receptor signaling. 
Immunity 13, 179-186. 
Schluns, K.S., Kieper, W.C., Jameson, S.C., and Lefrancois, L. (2000). Interleukin-7 mediates 
the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1, 426-432. 
Screpanti, I., Morrone, S., Meco, D., Santoni, A., Gulino, A., Paolini, R., Crisanti, A., 
Mathieson, B.J., and Frati, L. (1989). Steroid sensitivity of thymocyte subpopulations during  
intrathymic differentiation effects of 17β-estradiol and dexamethazone on subsets expressing 
T cell antigen receptor or IL-2 receptor. J. Immunol. 142, 3378-3383. 
Silver, A.C., Arjona, A., Walker, W.E., and Fikrig, E. (2012). The circadian clock controls 
Toll-like receptor 9-mediated innate and adaptive immunity. Immunity 36, 251-261. 
So, A.Y.L., Bernal, T.U., Pillsbury, M.L., Yamamoto, K.R., and Feldman, B.J. (2009). 
Glucocorticoid regulation of the circadian clock modulates glucose homeostasis. Proc. Natl. 
Acad. Sci. USA. 106, 17582-17587. 
Suzuki, K., Hayano, Y., Nakai, A., Furuta, F., and Noda, M. (2016). Adrenergic control of the 
adaptive immune response by diurnal lymphocyte recirculation through lymph nodes. J. Exp. 
Med. 213, 2567-2574. 
Tani-ichi, S., Shimba, A., Wagatsuma, K., Miyachi, H., Kitano, S., Imai, K., Hara, T., and 
 24 
Ikuta, K. (2013). Interleukin-7 receptor controls development and maturation of late stages of 
thymocyte subpopulations. Proc. Natl. Acad. Sci. USA. 110, 612-617. 
Tokoyoda, K., Egawa, T., Sugiyama, T., Choi, B.I., and Nagasawa, T. (2004). Cellular niches 
controlling B lymphocyte behavior within bone marrow during development. Immunity 20, 
707-718. 
Tronche, F., Kellendonk, C., Kretz, O., Gass, P., Anlag, K., Orban, P.C., Bock, R., Klein, R., 
and Schutz, G. (1999). Disruption of the glucocorticoid receptor gene in the nervous system 
results in reduced anxiety. Nat. Genet. 23, 99-103. 
Yajima, T., Nishimura, H., Sad, S., Shen, H., Kuwano, H., and Yoshikai, Y. (2005). A novel 







Figure 1. GRs control IL-7R expression and distribution of T cells in a diurnal fashion. 
(A) Flow cytometry of IL-7R expression on CD4+ T (CD3+CD4+CD25–NK1.1–), CD8+ T 
(CD3+8+), and Treg (CD3+4+25+) cells in spleen of Nr3c1fl/fl (control, Ctrl) and 
Nr3c1fl/flCd4-cre+ (GRcKO) mice at zeitgeber time (ZT) 16. (B) Flow cytometry of IL-7R 
expression on CD4+ T cells in spleen at ZT4 and ZT16. (C) IL-7R expression on splenic 
CD4+ and CD8 T+ cells was analyzed by flow cytometry. Mean fluorescence intensity (MFI) 
is shown over the course of the day (n = 3–4 per time point). (D) Il7r mRNA in splenic CD4+ 
and CD8+ T cells was analyzed by qPCR over the course of the day (n = 3–6). (E–H) 
Numbers of CD4+ T, CD8+ T, and Treg cells in peripheral blood (E, n = 3–7), lymph nodes 
(axillary, inguinal, and mesenteric, F, n = 3–5), spleen (G, n = 3–9), and Peyer’s patches (H, n 
= 3–4) of Nr3c1fl/fl (control) and Nr3c1fl/flCd4-cre+ (GRcKO) mice over the course of the day. 
ZT0/24 is double-plotted to facilitate viewing (C and E–H). All data are pooled from two to 
five independent experiments. Data are means ± SEM. One-way and two-way ANOVA 
(C–H). *p < 0.05, **p < 0.01, ***p < 0.001, n.s. not significant. See also Figure S1. 
 
Figure 2. IL-7R induction by GRs regulates the diurnal change in T cell distribution. 
(A) Flow cytometry of IL-7R expression on CD4+ T, CD8+ T, and Treg cells in spleen of 
wild-type (WT) and Il7rCNS1.GRE12m/12m (GRE12m, GR12) mice at ZT16. (B) IL-7R expression 
on splenic CD4+ and CD8+ T cells was analyzed by flow cytometry. Mean fluorescence 
intensity (MFI) is shown over the course of the day (n = 3–4 per time point). (C) Il-7r mRNA 
in splenic CD4+ and CD8+ T cells was analyzed by qPCR over the course of the day (n = 3–4). 
(D) GR binding to the CNS-1 region in CD4+ T cells was analyzed by ChIP assay (n = 3). 
(E–H) Numbers of CD4+ T, CD8+ T, and Treg cells in peripheral blood (E, n = 3–6), lymph 
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nodes (axillary, inguinal, and mesenteric, F, n = 3–5), spleen (G, n = 3–8), and Peyer’s 
patches (H, n = 3–6) of wild-type (WT) and GRE12m (GR12) mice over the course of the day. 
ZT0/24 is double-plotted to facilitate viewing (B and E–H). All data are pooled from two to 
five independent experiments. Data are means ± SEM. One-way and two-way ANOVA (B, C, 
and E–H); Student’s t-test (D). *p < 0.05, **p < 0.01, ***p < 0.001, n.s. not significant. See 
also Figures S2–S4. 
 
Figure 3. IL-7R induction by GRs controls the diurnal change in T cell distribution by 
regulating CXCR4 expression. 
(A and B) Flow cytometry of CXCR4 expression on splenic CD4+ T cells of Nr3c1fl/fl (control, 
Ctrl) and Nr3c1fl/flCd4-cre+ (GRcKO) mice (A) and wild-type (WT) and Il7rCNS1.GRE12m/12m 
(GRE12m, GR12) mice (B) at ZT4 and ZT16. (C and D) Mean fluorescence intensity (MFI) 
in control and Nr3c1fl/flCd4-cre+ mice (C) or wild-type (WT) and GRE12m (GR12) mice (D) 
at ZT4 and ZT16 (n = 3–4 per time point). (E and F) qPCR analysis of Cxcr4 mRNA in CD4+ 
and CD8+ T cells in spleens of Nr3c1fl/fl (control, Ctrl) and Nr3c1fl/flCd4-cre+ (GRcKO) mice 
(E) or wild-type (WT) and GRE12m (GR12) mice (F) over the course of the day (n = 3–4). 
(G and H) Chemotaxis of naïve CD4+ T cells toward CXCL12 was assessed by Transwell 
assay. T cells were isolated from lymph nodes of Nr3c1fl/fl (Ctrl) and Nr3c1fl/flCd4-cre+ 
(GRcKO) mice (G) or wild-type (WT) and GRE12m (GR12) mice (H) at ZT4 and ZT16 (n = 
3). (I and J) In vivo homing assay. Mice were sacrificed at ZT4 or ZT16, and naïve CD4+ T 
cells from lymph nodes of control CD45.1+ (C57BL/6) and CD45.2+ (Nr3c1fl/flCd4-cre+ 
[GRcKO] or GRE12m [GR12]) mice were mixed at a 1:1 ratio, labeled with CFSE, and 
transferred into CD45.2+ C57BL/6 mice at ZT6 (Daytime) or ZT18 (Night), respectively. 
CFSE+ donor cells were analyzed after 1 hour in spleen, lymph nodes, and peripheral blood. 
Percentage of donor cells from CD45.1+ control mice and CD45.2+ mutant (Nr3c1fl/flCd4-cre+ 
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[I] or GRE12m [J]) mice in total CFSE+ donor cells of the indicated tissues normalized by 
pre-transfer percentage of donor cells are shown (n = 3–4). (K–M) Numbers of CD4+ T, 
CD8+ T, and Treg cells in peripheral blood (K, n = 3–5), lymph nodes (axillary, inguinal, and 
mesenteric, L, n = 3–5), and spleen (M, n = 3–5) of Cxcr4fl/fl (control, Ctrl) and 
Cxcr4fl/flCd4-cre+ (CXCR4cKO) mice over the course of the day. All data are pooled from 
two to three independent experiments. Data are means ± SEM. One-way and two-way 
ANOVA (E, F, and K–M). Student’s t-test (C, D, and G–J). *p < 0.05, **p < 0.01, ***p < 
0.001, n.s. not significant. See also Figure S5. 
 
Figure 4. Upregulation of CXCR4 expression by GRs induces T cell migration to 
CXCL12-producing cells. 
(A and B) Immunohistochemistry of spleen from Cxcl12-GFP mice. Wild-type T cells were 
isolated from lymph nodes at ZT16, labeled with CMTMR, and transferred at ZT18. After 1 
hour, spleen was isolated and analyzed. White arrowheads indicate Cxcl12-GFP+ CD31+ 
vessels surrounded by CMTMR+ donor cells in the T cell zone (A) and B cell zone (B). Scale 
bars, 100 µm. (C and D) Immunohistochemistry of spleen from Il7–GFP mice. Wild-type T 
cells were isolated from lymph nodes at ZT16, labeled with CMTMR, and transferred at ZT18. 
After 1 hour, spleen was isolated and analyzed. White arrowheads indicate CD31+ vessels 
surrounded by IL-7+ stromal cells and CMTMR+ donor cells in the T cell zone (C) and B cell 
zone (D). Scale bars, 100 µm. (E) Immunohistochemistry of spleen from Cxcl12-GFP mice. T 
cells from lymph nodes of Nr3c1fl/fl (control) and Nr3c1fl/flCd4-cre+ (GRcKO) mice were 
labeled with CellTracker Deep Red (blue) and CMTMR (red), respectively, mixed at a 1:1 
ratio, and transferred into Cxcl12-GFP mice. After 1 hour, spleen was isolated and analyzed. 
White arrowheads indicate Cxcl12-GFP+ cells surrounded by CMTMR+ and CellTracker 
Deep Red+ donor cells. Scale bars, 100 µm. (F) Percentage of Nr3c1fl/fl (control) and 
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Nr3c1fl/flCd4-cre+ (GRcKO) T cells among total labeled cells present within 50 µm of 
Cxcl12-GFP+ cells in the B cell zone, T cell zone, and red pulp in (E) (n = 4). All data are 
pooled from two independent experiments. Data are means ± SEM. Student’s t-test, ***p < 
0.001. See also Figure S6. 
 
Figure 5. GRs regulate diurnal change in clonal expansion and immune response of T 
cells. 
(A) Naïve CD4+ and CD8+ T cells were isolated from lymph nodes at ZT16 and stimulated 
with anti-CD3 antibody, anti-CD28 antibody, and human IL-2 for 96 hours. Proliferation of 
naïve CD4+ and CD8+ T cells from Nr3c1fl/fl (control) and Nr3c1fl/flCd4-cre+ (GRcKO) mice 
was assessed by CFSE dilution assay. Divided cells were gated (upper panels) and compared 
(lower bar graphs, n = 3). (B) CD4+ and CD8+ T cells were isolated from lymph nodes at 
ZT16 and stimulated with anti-CD3 and anti-CD28 antibodies for 48 hours. IL-2R expression 
was analyzed by flow cytometry (left panels), and MFIs were compared (right bar graphs, n = 
3-4). (C) CD4+ and CD8+ T cells were isolated from lymph nodes at ZT16 and cultured with 
anti-CD3 and anti-CD28 antibodies for 48 hours, and then stimulated with human IL-2 for 90 
minutes. Intracellular staining of phosphorylated STAT5 was analyzed by flow cytometry 
(left panels), and MFIs were compared (right bar graph, n = 3). (D–G) Nr3c1fl/fl (control, Ctrl) 
and Nr3c1fl/flCd4-cre+ (GRcKO) mice (D and E) or wild-type (WT) and Il7rCNS1.GRE12m/12m 
(GR12m, GR12) mice (F and G) were infected with Listeria monocytogenes expressing 
ovalbumin (rLM-OVA) at ZT4 and ZT16. After 7 days (168 hours), OVA257-264/Kb MHC 
tetramer+ cells were analyzed by flow cytometry. Proportion of MHC tetramer+ cells in CD8+ 
T cells (D and F, and left bar graphs in E and G) and numbers of MHC tetramer+ cells (right 
bar graphs in E and G) in Nr3c1fl/fl and Nr3c1fl/flCd4-cre+ mice (n = 4–5) or wild-type and 
GR12m mice (n = 5–6) are shown. All data are pooled from two to three independent 
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experiments. Data are means ± SEM. Student’s t-test, *p < 0.05, **p < 0.01, n.s. not 
significant. See also Figure S7. 
 
Figure 6. GRs control differentiation of Th subsets and humoral immune responses. 
(A–C) Nr3c1fl/fl (control, Ctrl) and Nr3c1fl/flCd4-cre+ (GRcKO) mice were immunized with 
OVA at ZT4 or ZT16. After 12 days (288 hours), PD-1+CXCR5+ Tfh cells, GL7+CD95+ 
germinal center B cells, and IgG1+ B cells were analyzed at ZT4 or ZT16, respectively, by 
flow cytometry. Flow cytometric profiles (upper panels) and the proportions and numbers 
(lower bar graphs) of Tfh cells (A), GL7+ germinal center B cells (B), and IgG1+ B cells (C) 
(n = 4–8). (D) Nr3c1fl/fl (control, Ctrl) and Nr3c1fl/flCd4-cre+ (GRcKO) mice were immunized 
with NP-OVA at ZT4 and ZT16. After 20 days, mouse serum was recovered at ZT4 and ZT16, 
respectively, and the levels of NP-specific immunoglobulins were measured by ELISA (n = 
5–7). (E) Proportion of CXCR5+PD-1+ Tfh cells, GL7+CD95+ germinal center B cells, and 
IgG1+ B cells in Peyer’s patches of Nr3c1fl/fl (control, Ctrl) and Nr3c1fl/flCd4-cre+ (GRcKO) 
mice analyzed at ZT16 by flow cytometry. (F) Cell numbers of the cell populations at ZT4 
and ZT16 in (E) (n = 4–5). All data are pooled from two to three independent experiments. 
Data are means ± SEM. Student’s t-test, *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure 
S7. 
 
Figure 7. GRs support maintenance of memory CD4+ T cells by inducing IL-7R 
expression. 
(A) Th2 cells were induced from naïve CD4+ T cells isolated from lymph nodes of Nr3c1fl/fl 
(control, Ctrl), Nr3c1fl/flCd4-cre+ (GRcKO), and Il7rCNS1.GRE12m/12m (GRE12m, GR12) mice. 
Flow cytometry was performed to detect CD4+ T cells in spleen of CD45.1+ mice at 4 weeks 
after transfer of CD45.2+ Th2 cells. (B) Flow cytometry of IL-7R expression on 
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CD4+CD45.2+ memory Th2 cells in spleen at ZT16. (C) qPCR analysis of Il-7r mRNA, in 
memory CD4 T cells in spleen at ZT4 and ZT16 (n = 3–4). Student’s t-test. (D) Numbers of 
memory CD4+ T cells in spleen (n = 5), lymph nodes (axillary, inguinal, and mesenteric, LN, 
n = 4), and lungs (n = 4). One-way ANOVA with Tukey’s multiple-comparisons test. (E) 
Flow cytometry of Bcl-2 expression in memory CD4+ T cells. All data are pooled from two to 






CONTACT FOR REAGENT AND RESOURCE SHARING 
 
Further information and requests for resources and reagents should be directed to the Lead 
Contact, Dr. Koichi Ikuta (ikuta.koichi.6c@kyoto-u.ac.jp). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Mice 
B6.SJL-Ptprca Pepcb/BoyJ (B6.CD45.1 congenic), B6.Cg-Tg(Cd4-cre)1Cwi (Cd4-cre) (Lee et 
al., 2001), B6.129-Nr3c1tm2Gsc (Nr3c1fl/fl) (Tronche et al., 1999), B6.129-Cxcr4tm2Tng 
(Cxcr4fl/fl) (Tokoyoda et al., 2004), B6.129-Il7rtm2Iku(Il7rfl/fl) (Tani-ichi et al., 2013), 
B6.129-Cxcl12tm2Tng (Cxcl12-GFP) (Ara et al., 2003), and B6.129-Il7tm1.1Iku (Il7–GFP) (Hara 
et al., 2012) mice were used. All mice were maintained under specific pathogen–free 
conditions in the Experimental Research Center for Infectious Diseases in the Institute for 
Frontier Life and Medical Sciences, Kyoto University. Experiments were performed on 
6–12-week-old male and female mice. For infection or immunization assays, experiments 
were performed on 8–14-week-old male and female mice. Each pair of control and mutant 
mice of the same sex from the same litter was analyzed simultaneously, and the data were 
pooled from multiple pairs of mixed sex derived from multiple litters, except for the 
experiments in Figures 2D, 3I, 3J, S4C, and S4D, where mice from the different litters were 
analyzed simultaneously. All procedures were carried out under Sevoflurane anesthesia to 
minimize animal suffering. Mice were housed in group under controlled conditions of 
humidity, temperature, and light (12-hr light/12-hr dark cycles). Food and water were 
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available ad libitum. All mouse protocols were approved by the Animal Experimentation 
Committee of the Institute for Frontier Life and Medical Sciences, Kyoto University. 
 
Generation of GRE Mutant Mice 
To construct a targeting vector, the following DNA fragments were assembled in vector 
pBluescript KS (+): a diphtheria toxin A cassette, a 1,822-bp fragment of the 5’ CNS1 
element of the IL-7Rα locus, a neomycin resistance gene cassette flanked by loxP sequences, 
and an 8,521-bp fragment containing a mutated CNS1 element and 3’ CNS1 region. In vitro 
mutagenesis of the CNS1 element was carried out using the QuikChange site-directed 
mutagenesis kit (Agilent Technologies). GRE1 and GRE2 mutations were as follows, with 
mutated nucleotides underlined: GRE1 wild-type, 5’-CTTTGTTCTTTTACATCTTCA-3’; 
GRE1m, 5’-CTTCACTGCTTTGAGTGCTCA-3’; GRE2 wild-type, 
5’-TAGCACATGCTGTACC-3’; and GRE2m, 5’-TAGCGAGTGCTGTACC-3’. The 
linearized vector was introduced into KY1.1 ES cells (C57BL/6 × 129S6/SvEvTac F1 
background) by electroporation, and homologous recombinants were screened by PCR. 
Targeted ES clones were confirmed by Southern blot analysis with 5’ and 3’ probes (Figures 
S2A–S2C). The neomycin resistance gene cassette was removed from the recombinant allele 
by infecting targeted ES clones in vitro with adenovirus expressing Cre recombinase, 
AdV-Cre (a kind gift of Dr. Izumu Saito of the Institute of Medical Science, The University 
of Tokyo). The resultant ES clones contained one copy of the loxP site 5’ of the mutated 
CNS1 element. ES clones were injected into ICR 8-cell embryos. Chimeric mice were bred 
with C57BL/6 mice, and GRE mutant mice were backcrossed onto the C57BL/6 background 




Recombinant Listeria monocytogenes expressing OVA (rLM-OVA) were described 
previously (Abe et al., 2015; Pope et al., 2001; Yajima et al., 2005). Mice were injected 
intravenously with 2.5 × 104 CFU rLM-OVA at ZT4 or ZT16. After 7 days (168 hours), 
spleen cells were stained with antibodies. Flow cytometry was performed after the cells were 





After perfusion, lungs were minced with scissors and incubated at 37°C for 1 hour in 
RPMI-1640 medium containing 10% FBS, 1 mg/ml collagenase D, and 50 µg/ml DNase I. 
Digested lung fragments were passed through a 40-µm strainer. Leukocytes were separated by 
centrifugation through 30% Percoll. After lysis of red blood cells, cells were analyzed by flow 
cytometry. 
 
Antibodies and Flow Cytometry 
Cells were prepared from the indicated organs and stained with antibodies for 20 minutes at 
4°C in PBS containing 0.05% NaN3 and 0.1% bovine serum albumin (BSA). Fluorescent dye- 
or biotin-conjugated antibodies against the following proteins were purchased from BD 
Bioscience, eBioscience, BioLegend, Invitrogen, or TONBO Biosciences: CD3ε (145-2C11), 
TCRβ (H57-597), CD4 (RM4.5), CD8α (53-6.7), CD11a (M17/4), CD25 (7D4), CD44 (IM7), 
NK1.1 (PK136), CD69 (H1.2F3), PD-1 (29F.1A12), CXCR4 (L276F12), CXCR5 (L138D7), 
CCR7 (4B12), CD62L (MEL-14), CD95 (Jo2), GL7 antigen (GL7) CD45R/B220 (RA3-6B2), 
CD19 (6D5), IgG1 (RMG1-1), IFN-γ (XMG1.2), IL-2 (JES6-5H4), IL-4 (11B11), IL-13 
(eBio 13A), E4BP4 (S2M-E19), GATA3 (16E10A23), CD45.2 (104), CD122 (TM-beta1), 
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CD127 (A7R34), phosophorylated-STAT5 (47), and Bcl-2 (A19-3). H-2Kb OVA G4 
tetramer-SIIGFEKL-PE was purchased from Medical and Biological Laboratories. 
Biotinylated monoclonal antibodies were detected with PE- or Brilliant Violet 
421–conjugated streptavidin (eBioscience). Viable cells were analyzed on a FACSCanto II 
flow cytometer (BD Biosciences) using the FlowJo software. In the figures, values in 
quadrants, gated areas, and interval gates indicate percentages in each population. 
 For intracellular staining of Bcl-2, GATA3, and E4BP4, T cells were stained for 
surface antigens, fixed, permeabilized, and stained with relevant antibodies using the Foxp3 
Staining Buffer Set (eBioscience). For intracellular staining of cytokine production, cultured 
CD4+ T cells were fixed, permeabilized, and stained with the relevant antibodies using IC 
Fixation Buffer (eBioscience). For intracellular staining for phosophorylated-STAT5, the 
cells were fixed, permeabilized in ice-cold methanol, and stained with anti-phosphorylated 
STAT5 antibody using the Foxp3 Staining Buffer Set. 
 
Cell Isolation 
Naïve CD4+ and CD8 T+ cells were purified from lymph nodes using EasySep Naïve CD4 and 
CD8 T-Cell Enrichment kits (STEMCELL Technologies). For qPCR analysis, CD4+ T 
(CD3+CD4+CD25–NK1.1–), CD8+ T (CD3+CD8+), Treg (CD3+CD4+CD25+), and Th2 
memory (CD4+CD45.2+) cells were sorted from thymus and spleen with a FACSAria II cell 
sorter (BD Biosciences). For immunohistochemistry, T cells were purified using the Pan T 
Cell Isolation Kit (Miltenyi Biotech). Density of white blood cells in peripheral blood was 
measured on a Celltacα MEK6450 fully automatic blood cell counter (Nihon Kohden Corp.) 
 
Cell Culture 
Purified T cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum 
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(FBS), 50 µM 2-mercaptethanol, and 10 mM HEPES (pH 7.4). To check IL-7Rα expression, 
cells were cultured with 10–8 M dexamethasone (Sigma) for 12 hours. For CFSE dilution 
assay, naïve CD4+ and CD8+ T cells were labeled with 2 µM CFSE (Dojindo Laboratories) in 
PBS at 37°C for 10 minutes. Cells were cultured with 4 µg/ml plate-bound anti-CD3 antibody, 
4 µg/ml soluble anti-CD28 antibody (PV-1, a kind gift from Dr. R. Abe at Tokyo University 
of Science), and 20 ng/ml human IL-2 (BioLegend). After 96 hours, cells were analyzed by 
flow cytometry. For in vitro survival assays, naïve CD4+ and CD8+ T cells were cultured with 
5 ng/ml IL-7 (BioLegend), and the proportions of propidium iodide–negative (i.e., living) 
cells were measured by flow cytometry at the indicated time points. 
 
Real-Time PCR 
Total RNA was isolated and reverse-transcribed using random primers. cDNA was analyzed 
by real-time RT-PCR using SYBR Green PCR Master Mix (QIAGEN) in an ABI7500 real 
time PCR system (Applied Biosystems). PCR results were normalized against the 
corresponding levels of Gapdh mRNA in cDNA from lymph node cells of wild-type mice. 
The following primer were used: Gapdh, 5’-CCTCGTCCCGTAGACAAAATG-3’ and 
5’-TCTCCACTTTGCCACTGCAA-3’; Il7r, 5'-GGATGGAGACCTAGAAGATG-3' and 
5'-GAGTTAGGCATTTCACTCGT-3'; Cxcr4, 5'-TGTTGCCATGGAACCGATCA-3' and 
5'-TGGTGGGCAGGAAGATCCTA-3'; Bcl2, 5'-TCGCTACCGTCGTGACTTC-3' and 
5'-AAACAGAGGTCGCATGCTG-3'; Bclxl, 5'-GGAGAGCGTTCAGTGATC-3' and 
5'-CAATGGTGGCTGAAGAGA-3'; Il4, 5'-AGGAGCCATATCCACGGATG-3' and 
5'-ACAGACGAGCTCACTCTCTG-3'; Il13, 5'-CAGCTCCCTGGTTCTCTCAC-3' and 
5'-ACACTCCATACCATGCTGCC-3'. 
 
Chromatin Immunoprecipitaion Assay (ChIP) 
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ChIP was performed as described previously (Lee et al., 2005). Briefly, 5 × 106 naïve CD4+ T 
cells were fixed in 1% formaldehyde for 5 minutes at room temperature. Soluble chromatin 
was immunoprecipitated with 5 µg of anti-GR antibody (BuGR-2, Merck) or mouse IgG 
(Jackson ImmunoResearch) overnight. Purified ChIP and input DNAs were measured by 
real-time PCR. PCR primers used for detecting the CNS-1 region were CNS-1/F, 
5’-CCATTGCTCACCCACAATCTC-3’; CNS-1/R, 5’-GCTATCACTCCATGGTGAAC-3’. 
 
Transwell Migration Assay 
Naïve CD4+ T cells were suspended in serum-free medium (RPMI 1640 containing 1% BSA, 
10 mM HEPES [pH 7.4]). Migration assay was performed in Transwell chambers with 
polycarbonate membranes with 5-µm pore diameter (Corning). Medium containing 100 ng/ml 
CXCL12 (TONBO) was added to the lower chamber, and the membranes were placed on top. 
T cells (1 × 105) were loaded into the upper chamber and cultured for 2 hours at 37°C. Cells 
in the lower chamber were collected and analyzed by flow cytometry. 
 
In Vivo Homing Assay 
Mice were sacrificed at ZT4 or ZT16, and purified naïve CD4+ T cells from control CD45.1+ 
(C57BL/6) and CD45.2+ (Nr3c1fl/flCd4-cre+ or Il7rCNS1.GRE12m/12m) mice were mixed at a 1:1 
ratio, labeled with CFSE, and transferred into CD45.2+ C57BL/6 mice (5 × 106 total) at ZT6 
or ZT18, respectively. The precise pre-transfer percentages of donor cells were determined by 
analyzing the remaining donor cells by flow cytometry. CFSE+ donor cells were analyzed 
after 1 hour in spleen, lymph nodes, and peripheral blood. Percentage of donor cells from 
CD45.1+ control mice and CD45.2+ mutant (Nr3c1fl/flCd4-cre+ or Il7rCNS1.GRE12m/12m) mice in 
total CFSE+ donor cells of the indicated tissues were normalized by the pre-transfer 




Mice were sacrificed at ZT16, and T cells purified from lymph nodes were labeled with 
CMTMR (Setareh Biotech) or CellTracker Deep Red (Thermo Fisher Scientific) and 
transferred into Cxcl12-GFP and Il7-GFP mice at ZT18. After 1 hour, spleen from recepient 
mice was fixed with 4% paraformaldehyde for 6 hours. Tissue sections were prepared and 
analyzed as described previously (Cui et al., 2014). After blocking, samples were stained with 
anti-TCRβ (H57-597), anti-B220 (RA3-6B2), anti-CD31 (MEC13.3), anti-rabbit IgG 
(Poly4064), anti-GFP rabbit polyclonal antibodies, and streptavidin–Brilliant Violet 421 to 
detect the T cell zone, B cell zone, and IL-7 signal, and then mounted with PermaFluor 





Dexamethasone 21-phosphate disodium salt (200 µg) (Sigma) or PBS was injected 
intraperitoneally at ZT0. After 4 hours (at ZT4), the mice were sacrificed. 
 
Caspase Assay 
Naïve CD4+ T cells were purified at ZT4 or ZT16, and cultured in medium for 3 hours 
without IL-7. Active caspase-3 expression was detected with CaspGLOW Fluorescein Active 
Caspase-3 Staining Kit (Thermo Fisher Scientific) by flow cytometry. 
 
Immunization 
Mice were immunized by intraperitoneal injection with 100 µg of OVA (grade V, Sigma 
Aldrich) emulsified in alum (Thermo Scientific) at ZT16. Splenocytes were isolated after 7 
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days and stimulated with 100 µg/ml OVA for 72 hours. After stimulation, cytokines in culture 
supernatant were measured by ELISA (eBioscience). Tfh cells (TCRβ+CD4+CD44+CXCR5+ 
PD-1+) were sorted, and their mRNA was purified. To analyze germinal center B cells, mice 
were immunized by intraperitoneal injection with 100 µg of OVA emulsified in alum at ZT4 
or ZT16. After 12 days, spleen cells were stained with antibodies and analyzed by flow 
cytometry. For antibody production, mice were immunized by intraperitoneal injection with 
100 µg of NP-OVA (LGC Biosearch Technologies) emulsified in alum at ZT16. After 20 
days, serum was collected and analyzed by ELISA as described previously (Hata et al., 2016). 
 
Induction of Th Subsets 
Naïve CD4+ T cells isolated at ZT4 and ZT16 were cultured with 4 µg/ml plate-bound 
anti-CD3, 4 µg/ml soluble anti-CD28, and 20 ng/ml hIL-2 in the presence of IL-12 (10 ng/ml) 
and anti-IL-4 antibody (5 ng/ml) for Th1 differentiation, or IL-4 (10 ng/ml) and anti-IFN-γ 
antibody (5 ng/ml) for Th2 differentiation. After 7 days, the cells were restimulated with 
PMA (50 ng/ml) and ionomycin (2 µg/ml) for 4 hours in the presence of Brefeldin A. After 
restimulation, cells were fixed, permeabilized, and stained with the indicated antibodies 
against cytokines. 
 
Generation of Memory CD4+ T Cells 
Naïve CD4+ T cells purified from Nr3c1fl/fl (Control), Nr3c1fl/flCd4-cre+ (GRcKO), or 
Il7rCNS1.GRE12m/12m (GRE12m) mice were cultured under Th2 conditions for 6 days. The 
effector cells (2.5 × 107) were transferred into B6.CD45.1+ mice. After 4 weeks, the recipient 
mice were sacrificed, and lymphocytes from spleen, lymph nodes, and lungs were analyzed 
by flow cytometry. 
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QUANTIFICATION AND STATISTICAL ANALYSIS 
 
All data are presented as means ± SEM. Comparisons between two samples were performed 
using the unpaired two-tailed Student’s t-test. One-way ANOVA analyses followed by 
Tukey’s multiple-comparisons test and two-way ANOVA analyses were used for multiple 
group comparisons. Statistical analyses were performed using the GraphPad Prism 7 software. 
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Legend to Supplemental Figures 
 
Figure S1, related to Figure 1: GRs upregulate IL-7Rα  expression in thymic Treg cells. 
(A) CD4+ T cells from lymph nodes of Nr3c1fl/fl (control) and Nr3c1fl/flCd4-cre+ (GRcKO) 
mice at ZT4 were cultured with or without 10–8 M dexamethasone (DEX) for 20 hours. IL-7R 
expression was analyzed by flow cytometry. (B) Surface IL-7R expression of thymocytes 
from Nr3c1fl/fl (control) and Nr3c1fl/flCd4-cre+ (GRcKO) mice at ZT16. (C) qPCR analysis of 
Il7r mRNA in thymocyte subsets at ZT16 (n = 3–4). (D) Flow cytometry of thymocyte 
subsets. (E) Cell numbers of thymocyte subsets: DN (CD4–8–), DP (CD4+8+), CD4+ SP 
(CD4+8–25–NK1.1–), and CD8+ SP (CD4–8+) (n = 18). (F) Numbers of Treg (CD4+25+) and 
natural killer T (NKT) (CD3+NK1.1+) cells (n = 18). (G) Flow cytometry of thymocyte 
maturation stages. (H) Cell numbers at the indicated stages of thymocyte maturation: stage 1 
(S1, CD69+TCRβint), stage 2 (S2, CD69+TCRβhigh), and stage 3 (S3, CD69–TCRβhigh) (n = 6). 
All data are pooled from two-four independent experiments. Data are means ± SEM. 
Student’s t-test, *p < 0.05. 
 
Figure S2, related to Figure 2: Generation of GRE mutant mice. 
(A) Schematic illustration of the IL-7Rα locus, targeting vector, and CNS1-targeted alleles. 
Boxes and the oval indicate exons and CNS1, respectively. Triangles indicate loxP sequences. 
Probes for Southern blot analysis are shown as horizontal bars. N, neomycin resistance gene 
cassette; E, EcoRV; S, SphI. (B) Point mutations in GRE1 and GRE2 in GRE mutant mice. X 
indicates point mutations in GR consensus motifs. (C) Southern blot analysis of targeted ES 
clones. Genomic DNA from two ES clones for each mutant was digested with EcoRV and 
SphI and hybridized with probes A and B, respectively. (D) IL-7R expression was analyzed 
by flow cytometry. CD4 T cells from lymph nodes of wild-type (WT) and Il7rCNS1.GRE12m/12m 
(GRE12m, GR12) at ZT4 mice were cultured with or without 10–8 M dexamethasone (DEX) 
 2 
for 20 hours. (E) Surface IL-7R expression on CD4+ T, CD8+ T, and Treg cells in spleen of 
WT, Il7rCNS1.GRE1m/1m (GRE1m, GR1), Il7rCNS1.GRE2m/2m (GRE2m, GR2), and 
Il7rCNS1.GRE12m/12m (GRE12m, GR12) mice at ZT16. (F) qPCR analysis of Il7r mRNA 
expression in splenic CD4+ T and CD8+ T cells of wild-type, GRE1m, GRE2m, and GRE12m 
mice at ZT16 (n = 4). All data are pooled from two to three independent experiments. Data 
are means ± SEM. Student’s t-test, *p < 0.05, **p < 0.01, ***p < 0.001, n.s. not significant. 
 
Figure S3, related to Figure 2: Phenotypes of GRE mutant and T cell-specific 
IL-7R–deficient mice. 
(A) Surface IL-7R expression in thymocytes of wild-type (WT) and Il7rCNS1.GRE12m/12m 
(GRE12m, GR12) mice at ZT16. (B) QPCR analysis of Il7r mRNA in thymocyte subsets at 
ZT16 (n = 3–4). (C) Cell numbers of thymocyte subsets: DN (CD4–8–), DP (CD4+8+), CD4+ 
SP (CD4+8–25–NK1.1–), and CD8+ SP (CD4–8+) cells (n = 6). (D) Numbers of Treg 
(CD4+25+) and NKT (CD3+NK1.1+) cells in thymus (n = 6). (E–G) Numbers of CD4+ T, 
CD8+ T, and Treg cells at ZT4 and ZT16 in peripheral blood (E), spleen (F), and lymph nodes 
(axillary, inguinal, and mesenteric, G) of Il7rfl/fl (control, Ctrl) and Il7rfl/flCd4-cre+ 
(IL-7RcKO) mice (n = 5–8). All data are pooled from two to four independent experiments. 
Data are means ± SEM. Student’s t-test, *p < 0.05, **p < 0.01, ***p < 0.001. 
 
Figure S4, related to Figure 2: IL-7R induction by GRs support survival of T cells. 
(A and B) Naïve CD4+ and CD8+ T cells were isolated from lymph nodes of Nr3c1fl/fl (control, 
closed circle) and Nr3c1fl/flCd4-cre+ (GRcKO, open circle) mice (A) or wild-type (WT, closed 
square) and Il7rCNS1.GRE12m/12m (GRE12m, open square) mice (B) at ZT16, and cultured with 
IL-7 for 6 days. Live cells were counted by flow cytometry at the indicated time points (n = 3). 
(C and D) CD44low CD4+ T cells were purified from lymph nodes of CD45.1+ (C57BL/6) and 
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CD45.2+ (Nr3c1fl/flCd4-cre+, GRcKO [C, n = 3] or GRE12m, GR12 [D, n = 4]) mice at ZT4, 
mixed at a 1:1 ratio, labeled with CFSE, and transferred into CD45.2+C57BL/6 mice (5 × 106 
total). CFSE+ donor cells were analyzed after 8 days at ZT4 in spleen, lymph nodes (LN), and 
peripheral blood. Percentage of CD45.2+ and CD45.2– populations in CFSE+CD4+ T cells is 
shown. (E) Activated caspase 3 was analyzed by flow cytometry in CD4+ T cells purified 
from lymph nodes at ZT4 or ZT16 of Nr3c1fl/fl (control) and Nr3c1fl/flCd4-cre+ (GRcKO) mice 
after 3 hours of culture without IL-7 (n = 3–4). (F) Flow cytometry of Bcl2 expression in 
CD4+ T and CD8+ T cells in spleens of Nr3c1fl/fl (control) and Nr3c1fl/flCd4-cre+ (GRcKO) 
mice at ZT16. (G) qPCR analysis of Bcl2 and Bclxl mRNA of CD4+ T and CD8+ T cells in 
spleens of Nr3c1fl/fl (control) and Nr3c1fl/flCd4-cre+ (GRcKO) mice at ZT16 (n = 4). (H) 
qPCR analysis of Bcl2 and Bclxl mRNA of CD4+ SP and CD8+ SP thymocytes from Nr3c1fl/fl 
(control) and Nr3c1fl/flCd4-cre+ (GRcKO) mice at ZT16 (n = 4). (I) Bcl2 expression in CD4+ 
T and CD8+ T cells in spleens of wild-type (WT) and Il7rCNS1.GRE12m/12m (GRE12m, GR12) 
mice at ZT16 was analyzed by flow cytometry. (J) qPCR analysis of Bcl2 and Bclxl mRNA 
of CD4+ T and CD8+ T cells in spleens of wild-type and GRE12m mice at ZT16 (n = 4). (K) 
qPCR analysis of Bcl2 and Bclxl mRNA in CD4+ SP and CD8+ SP thymocytes from wild-type 
(WT) and GRE12m (GR12) mice at ZT16 (n = 4). All data are pooled from two to three 
independent experiments. Data are means ± SEM. Student’s t-test, *p < 0.05, **p < 0.01, 
***p < 0.001. 
 
Figure S5, related to Figure 3: CXCR4 deficiency does not affect T cell survival. 
(A) CD44, CD62L, CCR7, and CD11a expression levels were analyzed by flow cytometry at 
ZT16 in CD4+ T and CD8+ T cells of spleen from Nr3c1fl/fl (control) and Nr3c1fl/flCd4-cre+ 
(GRcKO) mice. (B) Surface IL-7R expression in CD4 T and CD8 T cells of spleen from 
Cxcr4fl/fl (control) and Cxcr4fl/flCd4-cre+ (CXCR4cKO) mice at ZT16. (C) Bcl2 expression 
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was analyzed by flow cytometry in CD4+ T and CD8+ T cells of spleen from Cxcr4fl/fl 
(control) and Cxcr4fl/flCd4-cre+ (CXCR4cKO) mice at ZT16. (D) Naive CD4+ T cells in 
lymph nodes of C57BL/6 (CD45.1+) and Cxcr4fl/fl (control) or Cxcr4fl/flCd4-cre+ 
(CXCR4cKO) (CD45.2+) mice were purified at ZT4, mixed at a 1:1 ratio, labeled with CFSE, 
and transferred into C57BL/6 (CD45.2+) mice (5 × 106 cells in total). After 8 days, CFSE+ 
donor cells were analyzed at ZT4 in spleen, lymph nodes (LN), and peripheral blood. 
Percentages of CD45.2+ and CD45.2– cells in CFSE+ CD4+ T cells are shown (n = 3). (E) 
Mice were injected with dexamethasone at ZT0. Expression of IL-7R and CXCR4 (mean 
fluorescence intensity, MFI) and the numbers of splenic CD4+ T cells after 4 hours of 
dexamethasone administration in vivo at ZT4 (n = 3). (F) Mice were injected with 10 µg IL-7 
at ZT0 or ZT8, respectively. Expression of CXCR4 of splenic CD4+ T cells after 4 hours of 
intravenous IL-7 administration in vivo at ZT4 or ZT12. (G) Naïve CD4+ T cells were 
purified from spleen at ZT4 or ZT8, and stimulated with or without IL-7 (10 ng/ml) for 10 
and 20 hours in vitro. CXCR4 expression was analyzed by flow cytometry. All data are 
pooled from two to three independent experiments. Data are means ± SEM. Student’s t-test, 
*p < 0.05, **p < 0.01, n.s. not significant. 
 
Figure S6, related to Figure 4: CXCR4 induces T cell migration into the 
CXCL12-expressing T cell zone. 
(A–C) Immunohistochemistry of Peyer’s patches from Cxcl12-GFP mice (A and B) or 
Il7-GFP mice (C). Wild-type T cells were isolated from lymph nodes at ZT16, labeled with 
CellTracker Deep Red (A and B) or CMTMR (C), and transferred at ZT18 into Cxcl12-GFP 
or Il7-GFP mice. After 1 hour, anti-B220, anti-TCRβ, and anti-CD31 antibodies were used to 
detect the B cell zone, T cell zone, and vessels, respectively. Scale bars, 100 µm. (D) 
Immunohistochemistry of Peyer’s patches from Cxcl12-GFP mice. T cells from Nr3c1fl/fl 
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(control) and Nr3c1fl/flCd4-cre+ (GRcKO) mice were isolated from lymph nodes at ZT16 and 
labeled with CellTracker Deep Red (blue) and CMTMR (red), respectively, mixed in equal 
proportions, and transferred at ZT18 into Cxcl12-GFP mice. After 1 hour, anti-TCRβ 
antibody (cyan) was used to detect the T cell zone. Scale bar, 100 µm. (E) Percentage of 
Nr3c1fl/fl (control) and Nr3c1fl/flCd4-cre+ (GRcKO) T cells among total labeled cells present 
within Peyer’s patches in (D) (n = 4). All data are pooled from two independent experiments. 
Data are means ± SEM. Student’s t-test, *p < 0.05. 
 
Figure S7, related to Figures 5 and 6: GRs control differentiation of Th subsets and 
immune response of B cells. 
(A) Naïve CD4+ and CD8+ T cells were isolated from spleen of Nr3c1fl/fl (control) and 
Nr3c1fl/flCd4-cre+ (GRcKO), wild-type (WT), and Il7rCNS1.GRE12m/12m (GRE12m, GR12) mice, 
at ZT4 and ZT16 and stimulated with anti-CD3 and CD28 antibodies for 96 hours. 
Proliferation was assessed by CFSE dilution assay. Gates were set for the divided cells and 
the cells with more than 4 times divisions. Percentage of each cell population was shown (n = 
3). (B) Naïve CD4+ and CD8+ T cells were isolated from lymph nodes of wild-type (WT) and 
Il7rCNS1.GRE12m/12m (GRE12m, GR12) mice at ZT16. The cells were labeled with CFSE, and 
cultured with anti-CD3 antibody, anti-CD28 antibody, and human IL-2 for 96 hours (upper 
panels). The cells were stimulated with anti-CD3 and anti-CD28 antibodies for 48 hours, and 
their IL-2R expression was assessed (middle and lower panels). (C) Intracellular cytokine 
staining in naive CD4+ T cells of Nr3c1fl/fl (control, Ctrl) and Nr3c1fl/flCd4-cre+ (GRcKO) 
mice, isolated from lymph nodes at ZT16 and cultured under Th1 and Th2 conditions. (D) 
Frequency of IFN-γ+ cells under Th1 conditions and IL-4+ and IL-13+ cells under Th2 
conditions (n = 6–7). Naive CD4+ T cells were isolated from lymph nodes at ZT4 and ZT16. 
(E) E4BP4 and GATA3 expression in CD4+ T cells isolated from lymph nodes at ZT16 and 
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cultured under Th2 conditions for 48 hours. (F and G) Nr3c1fl/fl (control) and 
Nr3c1fl/flCd4-cre+ (GRcKO) mice were immunized with OVA at ZT16. One week after 
injection, spleen cells were isolated at ZT16 and stimulated with OVA for 3 days. Protein 
levels of IL-4 and IL-13 in supernatant (n = 4) (F) and mRNA levels of IL-4 and IL-13 in 
sorted PD-1+CXCR5+ follicular helper T (Tfh) cells (G) (n = 6). (H) Intracellular cytokine 
staining in naïve CD4+ T cells of wild-type (WT), and Il7rCNS1.GRE12m/12m (GRE12m, GR12) 
mice, isolated from lymph nodes at ZT16 and cultured for IFN-γ and IL-2 under Th1 
conditions and for IL-4 and IL-13 under Th2 conditions. (I) Wild-type (WT), and 
Il7rCNS1.GRE12m/12m (GRE12m, GR12) mice were immunized with OVA at ZT4 or ZT16. After 
12 days (288 hours), CXCR5+PD-1+ follicular helper T cells (Tfh), GL7+CD95+ 
germinal-center B cells, and IgG1+ B cells were analyzed in spleen at ZT4 or ZT16, 
respectively, by flow cytometry (n = 3–8). (J) Numbers of CXCR5+PD-1+ Tfh cells, 
GL7+CD95+ germinal center B cells, and IgG1+ B cells in Peyer’s patches of wild-type (WT), 
and Il7rCNS1.GRE12m/12m (GRE12m, GR12) mice at ZT16 (n = 4). All data are pooled from two 
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